| Source: |
| Type: |
| Tumor cell cycle arrest refers to the process by which cancer cells stop progressing through the cell cycle, which is the series of phases that a cell goes through to divide and replicate. This arrest can occur at various checkpoints in the cell cycle, including the G1, S, G2, and M phases.
S, G1, G2, and M are the four phases of mitosis. |
| 7214- | GAs, | Ginkgolic Acid Suppresses Nasopharyngeal Carcinoma Growth by Inducing Apoptosis and Inhibiting AKT/NF-κB Signaling |
| - | vitro+vivo, | NPC, | CNE2 |
| 7211- | GBE, | Ginkgo Biflavones Cause p53 Wild-Type Dependent Cell Death in a Transcription-Independent Manner of p53 |
| - | in-vitro, | CRC, | HCT116 |
| 7103- | GEN, | A Comprehensive Review of Genistein's Effects in Preclinical Models of Cervical Cancer |
| - | Review, | Cerv, | NA |
| 7102- | GEN, | Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits |
| - | Review, | Var, | NA |
| 2997- | GEN, | Genistein Inhibition of Topoisomerase IIα Expression Participated by Sp1 and Sp3 in HeLa Cell |
| - | in-vitro, | Cerv, | HeLa |
| 1504- | GEN, | Epigenetic targets of bioactive dietary components for cancer prevention and therapy |
| - | Review, | NA, | NA |
| 1435- | GEN, | SFN, | The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| 7118- | GEO2, | Germanium oxide inhibits the transition from G2 to M phase of CHO cells |
| - | in-vitro, | Ovarian, | NA |
| 6562- | Ger, | Potential Effects of Geraniol on Cancer and Inflammation-Related Diseases: A Review of the Recent Research Findings |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6565- | Ger, | Geraniol and geranyl acetate induce potent anticancer effects in colon cancer Colo-205 cells by inducing apoptosis, DNA damage and cell cycle arrest |
| - | in-vitro, | CRC, | COLO205 |
| 7287- | GGB, | Rad, | Ginsenoside Rg3 enhances the radiosensitivity of lung cancer A549 and H1299 cells via the PI3K/AKT signaling pathway |
| - | in-vitro, | Lung, | NA |
| 7136- | GI, | [6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2 |
| - | vitro+vivo, | NSCLC, | H1650 |
| 7139- | GI, | 6-Shogaol Exhibits a Promoting Effect with Tax via Binding HSP60 in Non-Small-Cell Lung Cancer |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Melanoma, | A375 | - | in-vitro, | GBM, | U251 |
| 7138- | GI, | 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Lung, | A549 |
| 7245- | Gink, | Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity |
| - | vitro+vivo, | Pca, | DU145 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Nor, | MCF10 |
| 7246- | Gink, | Biflavone Ginkgetin, a Novel Wnt Inhibitor, Suppresses the Growth of Medulloblastoma |
| - | in-vitro, | GC, | DAOY | - | in-vitro, | MB, | D283 |
| 7250- | Gink, | Ginkgetin from Ginkgo biloba: mechanistic insights into anticancer efficacy |
| - | Review, | Var, | NA |
| 7260- | Gink, | Ginkgetin: A natural biflavone with versatile pharmacological activities |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
| 7264- | Gink, | Anti-tumor effect of ginkgetin on human hepatocellular carcinoma cell lines by inducing cell cycle arrest and promoting cell apoptosis |
| - | vitro+vivo, | HCC, | HepG2 | - | NA, | HCC, | SK-HEP-1 |
| 7267- | Gink, | Neuroprotective Potential of Biflavone Ginkgetin: A Review |
| - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 7259- | Gink, | Ginkgetin induces apoptosis via activation of caspase and inhibition of survival genes in PC-3 prostate cancer cells |
| - | in-vitro, | Pca, | PC3 |
| 7258- | Gink, | Ginkgetin inhibits the growth of DU−145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity |
| - | vitro+vivo, | Pca, | DU145 | - | in-vitro, | CRC, | HCT116 |
| 7284- | Gins, | 5-FU, | Ginsenoside Rg3 enhances the anticancer effect of 5-FU in colon cancer cells via the PI3K/AKT pathway |
| - | vitro+vivo, | CRC, | SW-620 | - | in-vitro, | CRC, | LoVo |
| 3526- | GoldNP, | Rad, | Advances in nanoparticle-based radiotherapy for cancer treatment |
| - | Review, | Var, | NA |
| 7338- | Gra, | Pharmacological Activities of Soursop (Annona muricata Lin.) |
| - | Review, | Var, | NA |
| 7335- | Gra, | Effect of Annona muricata (Soursop) on Patients with Cancer: A Systematic Review |
| - | Review, | Var, | NA |
| 2438- | Gra, | Emerging therapeutic potential of graviola and its constituents in cancers |
| - | Review, | Var, | NA |
| - | in-vitro, | NMSC, | A431 | - | in-vitro, | NMSC, | UW-BCC1 | - | in-vitro, | Nor, | NHEKn |
| - | in-vitro, | SCC, | SCC25 |
| 836- | Gra, | Graviola: A Novel Promising Natural-Derived Drug That Inhibits Tumorigenicity and Metastasis of Pancreatic Cancer Cells In Vitro and In Vivo Through Altering Cell Metabolism |
| - | vitro+vivo, | PC, | NA |
| 835- | Gra, | Annona muricata leaves induced apoptosis in A549 cells through mitochondrial-mediated pathway and involvement of NF-κB |
| - | in-vitro, | Lung, | A549 |
| 858- | Gra, | Annona muricata leaves induce G₁ cell cycle arrest and apoptosis through mitochondria-mediated pathway in human HCT-116 and HT-29 colon cancer cells |
| - | in-vitro, | CRC, | HT-29 | - | in-vitro, | CRC, | HCT116 |
| 856- | Gra, | https://pubmed.ncbi.nlm.nih.gov/33048613/ |
| - | in-vitro, | BC, | MCF7 |
| 855- | Gra, | Antiproliferative activity of ionic liquid-graviola fruit extract against human breast cancer (MCF-7) cell lines using flow cytometry techniques |
| - | in-vitro, | BC, | MCF7 |
| 1232- | Gra, | Graviola: A Systematic Review on Its Anticancer Properties |
| - | Review, | NA, | NA |
| 292- | HCA, | Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway |
| - | in-vitro, | AML, | K562 |
| 1638- | HCAs, | Anticancer potential of hydroxycinnamic acids: mechanisms, bioavailability, and therapeutic applications |
| - | Review, | Nor, | NA |
| 1643- | HCAs, | Mechanisms involved in the anticancer effects of sinapic acid |
| - | Review, | Var, | NA |
| 1649- | HCAs, | Anticancer Properties of Hydroxycinnamic Acids -A Review |
| - | Review, | Var, | NA |
| 7365- | HibSad, | Insight into the molecular evidence supporting the remarkable chemotherapeutic potential of Hibiscus sabdariffa L |
| - | Review, | Var, | NA |
| 7359- | HibSad, | Novel Insight into the Cellular and Molecular Signalling Pathways on Cancer Preventing Effects of Hibiscus sabdariffa: A Review - PubMed |
| - | Review, | Var, | NA |
| 7350- | HibSad, | Hibiscus polyphenol-rich extract induces apoptosis in human gastric carcinoma cells via p53 phosphorylation and p38 MAPK/FasL cascade pathway |
| - | in-vitro, | GC, | AGS |
| 7468- | HNK, | Honokiol and Its Emerging Role in Breast Cancer Therapy |
| - | Review, | BC, | NA |
| 7463- | HNK, | Honokiol Inhibits Colorectal Cancer Cell Growth: Involvement of Hsp27 as a Molecular Target |
| - | in-vitro, | CRC, | NA |
| 2875- | HNK, | Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | H460 | - | in-vitro, | SCC, | H226 |
| 2879- | HNK, | Honokiol Inhibits Lung Tumorigenesis through Inhibition of Mitochondrial Function |
| - | in-vitro, | Lung, | H226 | - | in-vivo, | NA, | NA |
| 2881- | HNK, | Honokiol Suppressed Pancreatic Cancer Progression via miR-101/Mcl-1 Axis |
| - | in-vitro, | PC, | PANC1 |
| 2864- | HNK, | Honokiol: A Review of Its Anticancer Potential and Mechanisms |
| - | Review, | Var, | NA |
| 2892- | HNK, | Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H460 | - | in-vitro, | Lung, | H385 | - | in-vitro, | Nor, | BEAS-2B |
| 2898- | HNK, | Honokiol Suppression of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastric Cancer Cell Biological Activity and Its Mechanism |
| - | in-vitro, | GC, | AGS | - | in-vitro, | GC, | NCI-N87 | - | in-vitro, | BC, | MGC803 | - | in-vitro, | GC, | SGC-7901 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:322 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid